Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.41 |
| ▸ | PRKDC | P78527 | 9/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15583146 | 0.94 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL24923149 | 0.93 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL16675649 | 0.93 | PRKDC (0.39) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL24923059 | 0.93 | ALOX5 (0.41) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL17246079 | 0.92 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL17735781 | 0.90 | ALOX5 (0.42) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL20232131 | 0.90 | ALOX5 (0.43) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL12158911 | 0.89 | ALOX5 (0.41) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL19287635 | 0.88 | PRKDC (0.37) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL17735780 | 0.88 | ALOX5 (0.39) | ALOX5PRKDCPIK3CDPIK3CBBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20220238815-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | LEF1, L1CAM, RAP1A | ALOX5 2606/4885PRKDC 3590/4885PIK3CD 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.